Another 132,000 sq. ft. of capacity is being added to the Indianapolis facility, following an earlier expansion round that went online in January. The additional 132,000 sq. ft. to the soon-to-be 333,000 sq. ft. total footprint will begin operations as of October 1, 2017. The facility will feature best-in-class technology and automation to ensure world-class performance, including 16,200 sq. ft. of cold storage space.
According to Richard Beeny, CEO of LSL, the fast-growing market is demanding more regulated storage capacity and supply chain solutions, and LSL is simply being responsive. He adds that the central location of the Indianapolis facility is a draw for many pharmaceutical and medical device companies looking for distribution and accessibility efficiencies. LSL has four US locations (Dallas, Indianapolis, Baltimore and Atlanta, which will now total 1.6 million sq. ft of capacity exclusively for life sciences products. In addition to the storage, it offers 3PL logistics services, including distribution, order to cash and regulatory compliance.